News
PMHS
0.053
NaN%
--
Weekly Report: what happened at PMHS last week (0615-0619)?
Weekly Report · 22h ago
Polomar Health Services Ends Merger and Licensing Agreements
TipRanks · 06/15 21:02
Weekly Report: what happened at PMHS last week (0608-0612)?
Weekly Report · 06/15 10:36
Weekly Report: what happened at PMHS last week (0601-0605)?
Weekly Report · 06/08 10:31
Polomar net loss narrows to US$25,377 in Q1 FY26; revenue rises to US$1.01 million
PUBT · 06/01 20:12
Weekly Report: what happened at PMHS last week (0525-0529)?
Weekly Report · 06/01 10:36
Weekly Report: what happened at PMHS last week (0518-0522)?
Weekly Report · 05/25 10:40
Polomar Health Services Delays Quarterly SEC Filing
TipRanks · 05/18 18:17
Polomar Health Services delays Q1 10-Q filing for period ended March 31, 2026
PUBT · 05/18 17:29
Weekly Report: what happened at PMHS last week (0511-0515)?
Weekly Report · 05/18 10:40
Polomar Health Services, Altanine waive closing conditions, amend merger agreement terms
PUBT · 05/15 21:19
Weekly Report: what happened at PMHS last week (0504-0508)?
Weekly Report · 05/11 10:36
Weekly Report: what happened at PMHS last week (0427-0501)?
Weekly Report · 05/04 10:33
Polomar Faces Dispute Over Terminated Distribution Agreement
TipRanks · 04/29 23:03
Weekly Report: what happened at PMHS last week (0420-0424)?
Weekly Report · 04/27 10:37
Weekly Report: what happened at PMHS last week (0413-0417)?
Weekly Report · 04/20 10:32
Weekly Report: what happened at PMHS last week (0406-0410)?
Weekly Report · 04/13 10:36
Weekly Report: what happened at PMHS last week (0330-0403)?
Weekly Report · 04/06 10:37
Polomar Health Services Delays Annual SEC Filing
TipRanks · 04/01 15:30
Polomar Health Services delays filing annual report, cites incomplete disclosures compilation
Reuters · 04/01 10:55
More
Webull provides a variety of real-time PMHS stock news. You can receive the latest news about Polomar Health through multiple platforms. This information may help you make smarter investment decisions.
About PMHS
Polomar Health Services, Inc. operates Polomar Specialty Pharmacy, LLC (Polomar Specialty Pharmacy), a State of Florida licensed retail compounding pharmacy. Polomar Specialty Pharmacy is also licensed as a Special Sterile Compounding Pharmacy, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The Company also owns SlimRx (www.slimrx.com), a weight-loss focused online platform that connects patients with licensed physicians to prescribe weight-loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin (VitaSlim and VitaSlim Plus). The Company also focuses on launching PoloMeds (polomeds.com) to fulfill prescriptions for diabetes medications, including metformin compounds, sulfonylureas, and insulin; compounded erectile dysfunction medications inhalable sildenafil and Polomar’s prescription only, exclusive dermatological formulations.